ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) Stock Price, Forecast & Analysis
Europe • Euronext Oslo • OSL:AZT • NO0010014632
AZT.OL Key Statistics, Chart & Performance
The current stock price of AZT.OL is 22.2 NOK. In the past month the price increased by 4.72%. In the past year, price increased by 52.47%.
AZT.OL Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to AZT.OL. When comparing the yearly performance of all stocks, AZT.OL turns out to be only a medium performer in the overall market: it outperformed 65.88% of all stocks.
AZT.OL Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to AZT.OL. AZT.OL is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
AZT.OL Financial Highlights
Over the last trailing twelve months AZT.OL reported a non-GAAP Earnings per Share(EPS) of 0.12.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 7.43% | ||
| ROA | 2.17% | ||
| ROE | 2.32% | ||
| Debt/Equity | 0.01 |
AZT.OL Forecast & Estimates
6 analysts have analysed AZT.OL and the average price target is 33.66 NOK. This implies a price increase of 51.62% is expected in the next year compared to the current price of 22.2.
For the next year, analysts expect an EPS growth of -2.61% and a revenue growth 4.69% for AZT.OL
AZT.OL Ownership
About AZT.OL
Company Profile
ArcticZymes Technologies ASA is a holding company, which engages in the development, manufacture, and marketing of immunomodulatory products and cold adapted marine enzymes. The company is headquartered in Tromso, Troms and currently employs 55 full-time employees. The company went IPO on 2005-11-04. As a life science company, Arcticzymes Technologies ASA is focused on the development, manufacturing, and commercialization of novel and high-quality recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. Some of the key features of the Company’s enzymes include cold activeness and salt tolerance. The Company’s divided into two operating segments; Enzymes and Corporate. Arcticzymes established logistic hubs in the United States and the Netherlands to serve its customers more efficiently.
Company Info
ARCTICZYMES TECHNOLOGIES ASA
Sykehusveien 23
Tromso TROMS NO
Employees: 53
Phone: 4777648900
ARCTICZYMES TECHNOLOGIES ASA / AZT.OL FAQ
What does AZT do?
ArcticZymes Technologies ASA is a holding company, which engages in the development, manufacture, and marketing of immunomodulatory products and cold adapted marine enzymes. The company is headquartered in Tromso, Troms and currently employs 55 full-time employees. The company went IPO on 2005-11-04. As a life science company, Arcticzymes Technologies ASA is focused on the development, manufacturing, and commercialization of novel and high-quality recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. Some of the key features of the Company’s enzymes include cold activeness and salt tolerance. The Company’s divided into two operating segments; Enzymes and Corporate. Arcticzymes established logistic hubs in the United States and the Netherlands to serve its customers more efficiently.
What is the stock price of ARCTICZYMES TECHNOLOGIES ASA today?
The current stock price of AZT.OL is 22.2 NOK. The price increased by 1.83% in the last trading session.
What is the dividend status of ARCTICZYMES TECHNOLOGIES ASA?
AZT.OL does not pay a dividend.
How is the ChartMill rating for ARCTICZYMES TECHNOLOGIES ASA?
AZT.OL has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Can you provide the sector and industry classification for ARCTICZYMES TECHNOLOGIES ASA?
ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) operates in the Health Care sector and the Biotechnology industry.
How is the valuation of ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) based on its PE ratio?
The PE ratio for ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) is 185. This is based on the reported non-GAAP earnings per share of 0.12 and the current share price of 22.2 NOK.